Home > Insider Trading > Filing (0000950142-22-000344)

Filing Details

Accession Number:: 0000950142-22-000344
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-01-13 21:32:42
Reporting Period:: 2022-01-11

Accepted Time:: 2022-01-13 21:32:42
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1868734	Cincor Pharma Inc.	CINC	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1356474	Gap Coinvestments Cda, L.p.	C/O General Atlantic Service Co.,L.p. 55 East 52Nd Street, 33Rd Floor New York NY 10055	No	No	Yes	No
1406817	L.p. (Bermuda) Gap	C/O Conyers Client Services Limited Clarendon House, 2 Church Street Hamilton D0 HM11	No	No	Yes	No
1467927	General Atlantic Genpar (Bermuda), L.p.	C/O Conyers Client Services Limited Clarendon House, 2 Church Street Hamilton D0 HM11	No	No	Yes	No
1793940	General Atlantic (Spv) Gp, Llc	C/O General Atlantic Service Co.,L.p. 55 East 52Nd St. 32Nd Floor New York NY 10055	No	No	Yes	No
1891495	General Atlantic (Cin), L.p.	C/O General Atlantic Service Co.,L.p. 55 East 52Nd Street, 33Rd Floor New York NY 10055	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.00001 Per Share ("Common Stock")	Acquisiton	2022-01-11	2,426,470	$0.00	2,426,470	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2022-01-11	1,700,000	$16.00	4,126,470	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See footnote
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Preferred Stock	Disposition	2022-01-11	8,250,000	$0.00	2,426,470	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect

Footnotes

Represents the automatic conversion of Series B Preferred Stock into shares of Common Stock of CinCor Pharma, Inc. (" the Issuer"), on a 3.4:1 basis immediately prior to the closing of the Issuer's initial public offering (the "IPO") which closed on January 11, 2022.
Reflects securities held directly by General Atlantic (CIN), L.P. ("GA CIN"), a Delaware limited partnership. The limited partners of GA CIN are the following investment funds (the "GA Funds"): General Atlantic Partners 100, L.P., a Delaware limited partnership ("GAP 100"), General Atlantic Partners (Bermuda) EU, L.P., a Bermuda limited partnership ("GAP Bermuda EU"), General Atlantic Partners (Lux) SCSp, a Luxembourg special limited partnership ("GAP Lux"), GAP Coinvestments CDA, L.P., a Delaware limited partnership ("GAPCO CDA"), GAP Coinvestments III, LLC, a Delaware limited liability company ("GAPCO III"), GAP Coinvestments IV, LLC, a Delaware limited liability company ("GAPCO IV"), and GAP Coinvestments V, LLC, a Delaware limited liability company ("GAPCO V").
The general partner of GA (CIN) is General Atlantic (SPV) GP, LLC, a Delaware limited liability company ("GA SPV"). The general partner of GAP Lux is General Atlantic GenPar, (Lux) SCSp, a Luxembourg special limited partnership ("GA GenPar Lux") and the general partner of GA GenPar Lux is General Atlantic (Lux) S.a.r.l., a Luxembourg company ("GA Lux"). The general partner of GAP Bermuda EU and the sole shareholder of GA Lux is General Atlantic GenPar (Bermuda), L.P., a Bermuda limited partnership ("GenPar Bermuda"). GAP (Bermuda) L.P. ("GAP (Bermuda) LP") is the general partner of GenPar Bermuda.
The general partner of GAP 100 is General Atlantic GenPar, L.P., a Delaware limited partnership ("GA GenPar"). General Atlantic, L.P., a Delaware limited partnership ("GA LP") is the general partner of GA GenPar and GAPCO CDA, the managing member of GAPCO III, GAPCO IV and GAPCO V, and the sole member of GA SPV. There are nine members of the management committee of GA LP (the "GA Management Committee"). The members of the GA Management Committee are also the members of the management committee of GAP (Bermuda) LP. Each of the members of the GA Management Committee disclaims ownership of the shares except to the extent he has a pecuniary interest therein.
The shares of Common Stock were purchased by GA CIN in the Issuer's IPO which closed on January 11, 2022, at a price of $16.00.